PMA device
Solia CSP S Leads
Biotronik, Inc. · Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN, Class III) · First FDA decision Feb 12, 2026, newest Apr 2, 2026Bradycardia and heart block
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
4
Naming "Solia CSP S"
MAUDE reports
75
Brand "Solia CSP S", since 2015
PubMed studies
0
Mentioning "Solia CSP S"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Solia CSP S Leads
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Solia CSP S LeadsPMA supplement
P950037-S288 · Decided Apr 2, 2026 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes (NVN) · Cardiology
- Solia CSP S 53; Solia CSP S 60PMA supplement
P950037-S280 · Decided Feb 12, 2026 · 114 days after receipt · Normal 180 Day Track
Device type: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes (NVN) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Pacemakers: Single-Chamber and Dual-Chamber Permanent Cardiac PacemakersNational analysisReview closedCAG-00063R3Updated Sep 17, 2026
- Single Chamber and Dual Chamber Permanent Cardiac PacemakersNational determinationOn the books20.8.3Updated Dec 2, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Solia CSP S", any status and sponsor, newest update first.
- BIO|STREAM.CSP StudyRecruiting
Biotronik SE & Co. KGNot on our public-company list
NCT07393009 · 1,000 participants (planned) · Start May 25, 2026 · Primary completion Feb 1, 2033
Device: Implantation of the Solia CSP S pacing lead for LBBAP · For: Cardiac Pacing; Cardiac Pacemaker; Implantable Cardioverter Defibrillator and 4 more
Sites: Adelaide, Australia; Melbourne, Australia; Linz, Austria · 46 sites in all
- BIO|MASTER.CSP StudyPivotal-lookingActive, not recruiting
Biotronik SE & Co. KGNot on our public-company list
NCT06620237 · 152 participants (planned) · Start Oct 4, 2024 · Primary completion Oct 2026
Device: Implantation of the Solia CSP S pacing lead for LBBAP · For: Cardiac Pacing, Artificial; Cardiac Pacemaker, Artificial; Cardiac Resynchronization Therapy Devices and 4 more
Sites: Adelaide, Australia; Clayton, Australia; Elizabeth Vale, Australia · 14 sites in all
- CSP-SOLIA-REGISTRYNot yet recruiting
Hospital SOS CardioResearch network
NCT07808554 · 300 participants (planned) · Start Nov 2, 2026 · Primary completion Mar 2, 2028
Device: Solia CSP S Lead · For: Left Bundle Branch Area Pacing
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Solia CSP S", and for the whole product code for context.
This brand
75 reports: 1 malfunction, 74 injury, 0 death
Whole product code NVN
202,094 reports: 87,136 malfunction, 110,708 injury, 4,019 death
Newest reports for this brand
- Solia CSP S 60Injury
1028232-2026-05094 · Received Oct 29, 2026 · Event dated Oct 27, 2026
Device type: Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Solia CSP S 60Injury
1028232-2026-05096 · Received Oct 29, 2026 · Event dated Oct 27, 2026
Device type: Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Solia CSP S 60Injury
1028232-2026-05050 · Received Oct 26, 2026 · Event dated Oct 22, 2026
Device type: Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Solia CSP S"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NVN.
- CapSureFix Novus LeadMedtronic, Inc. · PMA 2025
- CapSure Sense LeadMedtronic Cardiac Rhythm Disease Management · PMA 2020
- FINELINE II Sterox and Sterox EZ pace/sense leadsBoston Scientific · PMA 2026
- SelectSecure Lead Model 3830Medtronic Cardiac Rhythm Disease Management · PMA 2026
- Medtronic SelectSecure MRI SureScan LeadMedtronic Cardiac Rhythm Disease Management · PMA 2022
- Tendril STSAbbott Medical · PMA 2020
- Medtronic(R) Capsurefix Lead Model 4068,4067,4568Medtronic, Inc. · PMA 2020
- Tendril, Tendril St, Tendril Sts, and Optisense LeadsAbbott Medical · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.